RIG
ELV icon

Raveneur Investment Group’s Elevance Health ELV Stock Holding History

Raveneur Investment Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-140,257
Closed -$19.5M – 24
2016
Q1 		$19.5M Sell
140,257
-9,949
-7% -$1.33M 3.68% 7
2015
Q4 		$20.9M Buy
150,206
+7,806
+5% +$1.08M 7.53% 4
2015
Q3 		$19.9M Buy
142,400
+74,200
+109% +$11.2M 6.74% 6
2015
Q2 		$11.2M Buy
+68,200
New +$10.9M 4.04% 12

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Raveneur Investment Group's ELV Position: Q2 2016 in Review

Raveneur Investment Group sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 140,257 shares — an estimated $19.5M sold.

Raveneur Investment Group first reported a position in ELV in Q2 2015 and held it in 4 quarters. The position peaked at $20.9M in Q4 2015. 760 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

  • Raveneur Investment Group reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
  • Raveneur Investment Group sold 140,257 Elevance Health shares in Q2 2016, an estimated $19.5M.
  • Raveneur Investment Group first reported a position in Elevance Health in Q2 2015 and held it in 4 quarters.
  • Raveneur Investment Group's Elevance Health position peaked at $20.9M in Q4 2015.
  • 760 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Raveneur Investment Group's 13F filing for Q2 2016, filed 12 Aug 2016.